The C-suite selling cluster, while modest relative to market cap (~0.01% of $7.7B), is notable for its concentration at the CEO/CFO level and proximity to all-time highs. Monitor for any upcoming catalyst (e.g., data readout, financing) that could explain the selling. If the stock pulls back 5-10%, the selling may prove opportunistic rather than informational.
SYRE drugs
SYRE drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Sep 4 $88.98entry
- T+1 · 2mo ago +2.03%α +2.58% · $90.79
- T+5 · 2mo ago +2.05%α +3.25% · $90.80
- T+20 · 6w ago +4.20%α +3.60% · $92.72
- T+50 · todayOpen
- T+60 · in 14d Pending
Price Chart
How similar events traded
Executive Summary
CEO Cameron Turtle and CFO Scott Burrows sold a combined $810K in open-market sales on September 1, 2026. These sales follow a broader cluster of insider selling totaling ~$5.7M over the prior week, including CFO Burrows' $1.6M sale and other executives' option exercises and sales. The selling is concentrated at the C-suite level and occurs near all-time highs for the stock, which has a $7.7B market cap and 91% analyst bullishness.
Key Financial Metrics
Key Facts
- CEO Cameron Turtle sold 8,400 shares at $87.15 for $732K on 2026-09-01
- CFO Scott Burrows sold 900 shares at $86.25 for $78K on 2026-09-01
- Total open-market sales in this cluster: $810K
- Broader 7-day cluster includes CFO Burrows' $1.63M sale and other executives' option exercises and sales totaling ~$5.7M
- Stock trades near $87, near all-time highs with a $7.7B market cap
Financial Impact
$810K in open-market sales by CEO and CFO in this cluster; ~$5.7M in total insider sales over the past week
Risk Factors
- Insider selling may signal management's view that the stock is fully valued near all-time highs
- Option exercises followed by sales suggest insiders are monetizing equity, not accumulating
- Broader cluster of ~$5.7M in sales over 7 days increases the bearish signal
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-SYRE-1788485651450 |
Track record
36 reports on SYRE
8 of 12 bullish or bearish reports moved the stock their way by T+60. Best: +54.27% at T+60 after the Apr 13, 2026 report. 15 of 20 went positive at some point.
Filters
- Nov 3, 202613d ago 8-K Neutral 5/10 No price data
- Nov 3, 202613d ago Press Release Bearish 5/10 Entry $99.04 Now $99.37 −0.33% settles Feb 2
- Oct 12, 20265w ago Institutional Cluster Bullish 4/10 Entry $85.90 Now $99.37 +15.68% settles Jan 7
- Oct 9, 20265w ago SC 13D/A Neutral 3/10 Entry $85.90 Now $99.37 +15.68% settles Jan 7
- Oct 7, 20265w ago 8-K Bearish 5/10 Entry $80.85 Now $99.37 −22.91% settles Jan 4
- Oct 6, 20265w ago 424B5 Bearish 6/10 Entry $80.85 Now $99.37 −22.91% settles Jan 4
- Oct 5, 20266w ago Press Release Bearish 6/10 Entry $80.11 Now $99.37 −24.04% settles Dec 31
- Oct 5, 20266w ago 424B5 Bearish 5/10 Entry $80.11 Now $99.37 −24.04% settles Dec 31
- Oct 5, 20266w ago Press Release Bearish 5/10 Entry $80.11 Now $99.37 −24.04% settles Dec 31
- Oct 2, 20266w ago Insider Cluster Bearish 4/10 Entry $92.72 Now $99.37 −7.17% settles Dec 30
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers